Philippe Camus, M.D.

Dijon, France

Both apps are now back!

Back to drug

The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

XLIII.j

Bronchiectasis

In the case under discussion (PMID 17339311), the underlying inflammatory bowel disease may be the cause for bronchiectasis rather than the drug per se (Further information under PMIDs 8502168, 8315712, 17296657 and 26788078)

Publications

Price LC, Poullis A, Grubnic S, Kang JY, Rayner CF

Mesalazine-induced bronchiectasis and eosinophilia in a patient with ulcerative colitis: a case report.

Journal of the Royal Society of Medicine 2007 Mar;100;151-2 — 2007 Mar — 151-2